Our study suggested that Perillyl alcohol has a protective effect on the progression of MCI to AD, and its mechanism may be through inhibiting P-tau181and NF-light and aβ1-42, aβ1-40, and GFAP. Here, GFAP is linked to Alzheimer disease.